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O’Neill S, Greenberg RG, Haddad F, Katz E, Sereika J
Department of Vascular Surgery, Cleveland Clinic Foundation, 2411 Woodmere Drive,
Cleveland Heights, Cleveland, OH 44106, USA
PROSPECTIVE ANALYSIS OF FENESTRATED ENDOVASCULAR GRAFTING: INTERMEDIATE-TERM
OUTCOMES
Introduction—Aim of Study:
To assess the intermediate-term outcome following fenestrated grafting for juxtarenal aneurysms.
Materials/methods:
A prospective trial was conducted on patients with short proximal necks, at high-risk for open repair and
unacceptable (short proximal neck) for conventional endovascular repair. Devices were designed using CT
reconstructions. All patients were evaluated with CT, duplex ultrasound, and KUB at discharge, 1, 6, and 12
months and annually thereafter.
Results:
One hundred and twenty-three patients were treated (2001–2005). Mean age and aneurysm size were 77
years and 67 mm, respectively, and 83% were male. A total of 311 visceral vessels were treated (mean of
2.5 per patient), with the most common design incorporated two renal arteries and the SMA (56%). All
prostheses were implanted successfully without any acute visceral artery loss. The mean follow-up was 15
months (0–42 months). There were no ruptures or conversions. One patient died within 30 days of device
implantation. Kaplan–Meier estimates of survival at 1, 12, and 24 months are 0.99, 0.91, 0.85. Pre-discharge
imaging noted nine type I and type III endoleaks, which were all successfully treated. The 30-day
endoleak rate was 10% (all type II). Aneurysm sac size decreased (O5 mm) in 54, 75 and 79% at 6, 12 and
24 months. Two patients had sac enlargement within the 1st year, both associated with type II endoleaks.
In-stent stenoses occurred in six renal arteries and 1 SMA. All were successfully treated. Seven of 235
stented renal arteries occluded (two prior to discharge), one of which was recanalised. One patient had
component separation between the fenestrated and bifurcated pieces at 2 years and was treated with an
extension.
Conclusions:
The placement of endovascular prostheses with graft material incorporating the visceral arteries is safe and
effective at preventing rupture. However, meticulous follow-up to assess sac behavior and visceral ostia remains
critical to ensure optimal results.
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Al-Barjas HSA, Ariens RAS, Grant PJ, Scott DJA
The Academic Unit of Molecular Vascular Medicine, The LIGHT Laboratories, University of
Leeds, Flat 63 Park House Apartments, 11 Park Row, Leeds LS1 5HB, UK
HAEMOSTATIC RISK FACTOR CLUSTERING IN THE PATHOGENESIS OF ABDOMINAL AORTIC
ANEURYSMS (AAA)
Introduction—Aim of Study:
The intraluminal thrombus (ILT) is a common pathological feature associated with AAAs. ILT is associated with
AAA expansion and rupture. Thrombin generation is under the control of a cluster of haemostatic factors. The
aim of this study is to conduct a case-control study of 110 patients with AAA and 110 age-sexmatched controls to
look for differences in the haemostatic proteins associated with athero-thrombotic disease and thrombin
generation.EJVES Extra Vol 11, April 2006
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Demographic data and plasma samples were obtained from 110 AAA patients and 110 age-sex matched
controls. The demographic data (age, height, weight, waist: hip ratio, and ankle brachial pressure index) and
the cardiovascular risk factors (hypertension, hyperlipidaemia, myocardial infarction) are well matched. All
subjects had ultrasound scan to determine the size of the aneurysm. Plasma fibrinogen, Factor VII:C %, D-dimer,
tissue-type plasminogen activator (t-PA), thrombin anti-thrombin (TAT), and prothrombin fragments 1C2
(PF1C2) were measured. The results were analysed using Mann–Whitney U-test and are expressed as median
below. Correlations were performed using Spearman correlation.
Results:
Fibrinogen concentration was significantly higher in AAA patients (2.89 vs 2.53 g/L) p!0.0001. D-dimer was
significantly higher in AAA patients than controls (496.50 vs 108 ng/ml) p!0.0001. t-PA was significantly
higher in AAA patients than controls (10.75 vs 8.85 g/ml) p!0.0001. TAT and F1C2 were significantly higher
in AAA patients than controls (5.41 vs 1.95 &#956; g/l) and (1.19 vs 0.84 &#956;g/l), respectively, p!0.0001.
FVII:C% was not different between the AAA and controls. The AAA size was positively correlated
with fibrinogen, PF1C2, TAT, and D-dimer (p!0.008 rZ0.253, p! 0.003 rZ0.280, p!0.014 rZ0.234, p! 0.001
rZ0.423), respectively.
Conclusions:
This is the largest well-matched case-control study that demonstrates significantly high levels of athero-
thrombotic markers in AAA patients, which were positively correlated to AAA size.
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Mohan IV, Bray P, Harris JP, May J, Stephen MS, Bray AE, White GH
Department of Vascular Surgery, Royal Prince Alfred Hospital, Sydney, Lake Macquarie
Private Hospital, Newcastle, UK; Department of Vascular Surgery, Manchester Royal
Infirmary, Oxford Road, Manchester M13 9WL, UK
ENDOVASCULAR POPLITEAL ANEURYSMS REPAIR; SURPRISINGLY GOOD RESULTS!
Introduction—Aim of Study:
The success of endovascular techniques for the treatment of aortic aneurysms has led to the application of these
techniques for peripheral aneurysms. The aim of this study was to review our experience of popliteal aneurysms
using endovascular techniques.
Materials/Methods:
Twenty-five PA in 23 patients were treated over a 10-year period. All patients were male, median age 74 (range
56–83) years. Median aneurysm diameter was 32 (16–47) mm. Five were symptomatic and 19 asymptomatic.
Procedures were performed with local (16), regional (4), and general anaesthesia (4). All cases were approached
from an ipsilateral antegrade CFA puncture with an 8 Fr. sheath; heparin and an antiplatelet agent were given in
all cases. Ninteen patients were treated with the Haemobahn stent-graft, Viabahn (1), Passager (2), Aneurx (1),
and PTFE homemade device (1). Data were assessed using life table analysis, and expressed as cumulative
patency rates and standard error (SE).
Results:
Median follow-up was 20 (1–63) months. One month cumulative primary patency was 95.5% (SE 4.1%). Six-
month patency was 86.7% (SE 7.4%), 80.7% at 12 months (SE 7.8%), and 80.5% at 2 years (SE 11.2%). A distal
endoleak at 1 month settled spontaneously. There was one early occlusion, and a further graft occlusion at 10
months that was treated with thrombolysis. One further graft occlusion at 2 month without limb threatening
ischaemia was treated conservatively; another occluded at 4 months treated by femoro-popliteal bypass.
Cumulative secondary patency was 100% at 1 month and 88.9% at 6 (SE 7.2%), 12 (SE 8.6%)and 24 months (SE
10.9%).EJVES Extra Vol 11, April 2006
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Endovascular treatment of popliteal aneurysms in this series achieved patency rates similar to open surgery.
Aneurysm repair was performed without peroperative deaths and the risks associated with open surgery. It is
time to consider a larger multicentre study comparing the open and endovascular approach.
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Diehm N, Silvestro A, Makaloski V, Schmidli J, Shang A, Dai-Do D, Mahler F, Baumgartner I
Division of Angiology and Department of Cardiovascular Surgery, Swiss Cardiovascular
Center, Inselspital, University Hospital of Bern, Bern, Switzerland
INFLUENCE OF CARDIOVASCULAR RISK FACTORS ON DISTRIBUTION PATTERN OFATHEROSCLERO-
TIC LESIONS IN 2659 PATIENTS UNDERGOING PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF
PERIPHERAL ARTERIES
Introduction—Aim of Study:
Aim of this study is to correlate distribution patterns of atherosclerotic lesions in patients with peripheral
arterial occlusive disease (PAD) with cardiovascular risk factor profiles.
Materials/Methods:
Analysis is based on a consecutive series of 2659 patients (1583 men, 1076 women, 70G11 years) with chronic
symptomatic PAD of atherosclerotic origin undergoing primary endovascular treatment of lower extremity
arteries. Peripheral atherosclerotic disease manifestation was grouped into iliac (nZ1166), femoropopliteal
(nZ2151) and infrapopliteal (nZ888) disease defined according to target lesions treated. A multivariable
multinomial logistic regression analysis was performed to assess the relation of age, gender, diabetes mellitus,
arterial hypertension, hypercholesterolemia, cigarette smoking and serum creatinine levels with peripheral
atherosclerotic disease manifestation using femoropopliteal arteries as reference group.
Results:
Anatomical level of disease manifestation was strictly related to age with progressively more distal involvement
with increasing age.
Risk factor Iliac Femoropopliteal Infrapopliteal
RRR 95%-CI RRR RRR 95%-CI
Age (per year) 0.95 0.94–0.96 1 1.02 1.01–1.02
Male gender 1.32 1.09–1.59 1 1.23 1.06–1.41
Diabetes mellitus 0.59 0.49–0.72 1 1.68 1.47–1.92
Hypertension 1.17 0.99–1.39 1 1.06 0.92–1.22
Hypercholesterolemia 1.15 0.98–1.36 1 0.82 0.71–0.94
Current smoking 2.02 1.68–2.42 1 0.50 0.42–0.59
RRR, relative risk ratio.EJVES Extra Vol 11, April 2006Iliac disease was associated with male gender (RRR 1.32, pZ0.004), current cigarette smoking (RRR 2.02,
p!0.001) and hypercholesterolemia (RRR 1.21, pZ0.017), whereas the prevalence of diabetes mellitus was
significantly lower (RRR 0.59, p!0.001). Infrapopliteal disease was associated with male gender (RRR 1.23,
pZ0.005), and diabetes mellitus (RRR 1.68, p!0.001), while hypercholesterolemia and smoking were less
prevalent (RRR 0.82, pZ0.006 and RRR 0.50, p!0.001, respectively). Hypertension and creatinine demonstrated
a more diffuse distribution pattern.
Conclusions:
Distribution pattern of peripheral atherosclerotic disease manifestation varies significantly with age, gender, and
risk factor profile of patients. Younger age,male gender and smoking are associatedwith iliacdisease,whereasmale
gender and diabetes mellitus are associated with infrapopliteal disease. Descriptive findings of this large patient
series suggest profound differences in molecular mechanisms involved in peripheral atherosclerosis. Further
evidence is needed, and clarification might have considerable influence on therapeutic decisions in the future.
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Dias NV, Sonesson B, Koul B, Malina M, Ivancev K
Department of Vascular Diseases and Endovascular Centre, Malmo¨ University Hospital and
Thoracic Surgery, Lund University Hospital, Entrance 59-2nd floor, SE-205 02Malmo¨, Sweden
ENDOVASCULAR STENT-GRAFT REPAIR OF COMPLICATED ACUTE TYPE B DISSECTIONS—A 8-YEARS
EXPERIENCE
Introduction—Aim of Study:
Acute type B dissection is considered for surgery when medical therapy is not effective or if there is
malperfusion and/or rupture. The aim of this study is to analyze the experience of a single centre with
endovascular repair of complicated acute type B-dissections (EVR-ABD).
Materials/Methods:
Between January 1997 and December 2004 data for patients undergoing EVR-ABD was prospectively collected.
A retrospective analysis was performed.
Results:
Thrity-one patients (20 males, 74 (IQR: 64–79) years-old) underwent EVR-ABD. Indications for treatment were
rupture (22 patients), intractable pain and hypertension (6 patients), acute bowel ischemia (2 patients) and one
patient with transient paraplegia, lower limb and kidney ischemia. Until January 2001 homemade stent-grafts
were used in four patients. Thereafter commercially available stent-grafts were utilized. Five patients (16%) died
within 30 days of EVR-ABD (including 1 before 2001). Postoperative complications occurred in 15 patients (48%,
including one paraplegia converted into paraparesis after cerebrospinal fluid drainage, five strokes, three lower
limb ischemias, three myocardial infarctions, two pulmonary infections and one gastrointestinal infection).
During follow-up (median 19 (IQR: 14–31) months) six more deaths occurred, two due to stent-graft-related
causes and four due cardiac disease.
Conclusions:
Stent-graft repair of complicated acute type B dissections is valuable alternative to open surgical treatment.
Randomized controlled trials are required to clarify the role of EVR-ABD in patients under medical control.
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Stovring JB, Juul S, Henneberg EW, Thomsen G, Ostergaard L, Lindholt JS
Department of Vascular Surgery, Rigshospitalet, Copenhagen, Denmark
CAN LONG-TERM ANTIBIOTIC TREATMENT PREVENT PROGRESSION OF PERIPHERAL ARTERIAL
OCCLUSIVE DISEASE?
Introduction—Aim of Study:
The purpose was to investigate in a large, randomized, double-blinded, placebo-controlled trial, whether
antibiotic can prevent progression of peripheral arterial disease (PAD).
Materials/Methods:
Five hundred and seven patients were included; all patients had an established diagnosis of PAD. Their
mean age was 66 years (36–85), and 59% were males. Patients were randomized to Roxithromycin 300 mg
daily for 28 days. Baseline investigations were ankle blood pressure, ankle-brachial blood pressure index
(ABPI), walking distance, C. pneumoniae serology, cholesterol and medical history. Follow-up was performed
every 6 months. Primary events were defined as death, peripheral revascularisation and major lower limb
amputation. Secondary events were thrombosis, stroke, transient cerebral ischaemic attack and myocardial
infarction. Change in ABPI was also investigated. Data were analyzed mainly by Cox regression and linear
regression.EJVES Extra Vol 11, April 2006
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Five hundred and seven patients with PAD were randomized. Two patients withdrew. Of the remaining, 248
received roxithromycin and 257 received placebo. In the treatment-group 55% were sero-positive and 53% in the
placebo group. Mean follow-up was 2.1 years (range 0.06–5.1 years). In the placebo group, 27 died and
80 primary events occurred in total. In the treatment group, 31 died and 74 primary events were observed.
The hazard ratio of death was 1.13 (95% CI: 0.68; 1.90), and of primary events 0.92 (95% CI: 0.67; 1.26). Also on
secondary events and ABPI changes, no significant differences were found.
Conclusions:
Long-term treatment with roxithromycin is ineffective in preventing death, amputation, peripheral
revascularization, myocardial infarction, stroke, transient cerebral ischaemic attack, thrombosis and decline in
ABPI in patients with an established diagnosis of PAD.
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Sto¨tter L, Schaaf I, Bockelbrink A
Chirurgische Praxisklinik/IMSE-Institut f. med. Statistik d. TU Mu¨nchen, Achdorfer Weg 5,
D-84036 Landshut, Germany
COMPARATIVE OUTCOMES OF RADIOFREQUENCY ENDOLUMINAL ABLATION, INVAGINATION
STRIPPING AND CRYOSTRIPPING IN THE TREATMENT OF THE GREAT SAPHENOUS VEIN
Introduction—Aim of Study:
Prospective, randomised comparison of short-term and 1-year postoperative outcomes after (1) radiofrequency
endoluminal ablation (REA) of the great saphenous vein (GSV), (2) saphenofemoral junction (SFJ) ligation with
extended tributary ligation and invagination GSV stripping, and (3) SFJ ligation with extended tributary ligation
and GSV cryostripping.
Materials/Methods:
Sixty consenting patients were randomly allocated to three groups and treated contemporaneously over a 9-mo
period. Clinical, duplex Doppler, analogue scale pain scoring, and activity assessments were done at 1 day, and
at 1, 2, and 6 weeks, and then repeated at 1 year, adding patient satisfaction scoring and the CIVIQ 2 quality of
life questionnaire, specifically designed for lower limb venous insufficiency.
Results:
Immediate success was achieved in 19/20 REA limbs with one open segment with delayed occlusion that
subsequently spontaneously closed, in 20/20 invagination stripping limbs, and in 18/20 cryostripped limbs, two
having residual segments. Cumulative up to 6-week impairment scores, cumulative up to 6-week pain scores,
earlier return to full activity and work were all statistically superior for REA patients.
REA Invagination stripping Cryostripping
Immediate success rating 19/20 20/20 18/20
24 h free of hematoma patients 6 1 1
1-week free of hematoma patients 9 2 2
1-week hematoma surface area (cm2) 55* 109 150
Cumulative up to 6-week impairment score 2.8* 7.9 17.1
Cumulative up to 6-week pain score 4.6* 7.5 10.6
Physician global impression score 0.62* 0.86 1.38
Median days to normal activity 7* 14 12
Median days to return to work 7* 11 14
*Indicates p!0.05.EJVES Extra Vol 11, April 2006At 1 year, segmental recanalization on less then 10 cmwas detected in two REA patients and for all REA patients
the GSV trunk was sonographically no longer visible beginning from 10 cm below the SFJ. REA patients
ESVS Abstracts—2005 57continued to be significantly more satisfied with both their operative procedures and the cosmetic appearance of
the treated lower extremity compared to patients in the two other treatment cohorts.
Conclusions:
REA offers significant short-term, patient-oriented advantages over extended ligation and inversion or
cryostripping through 1 year.
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Schmedt CG, Steckmeier S, Sroka R, Ruppert V, Sadeghi-Azandaryani M, Steckmeier B
Department for Surgery, University of Munich, Munich, Germany
Klinikum der Universita¨t Mu¨nchen, Chirurgische Klinik—Innenstadt, Pettenkoferstrasse 8a,
D-80336 Mu¨nchen, Germany
COMPARISON OF RADIOFREQUENCYAND LASER FOR ENDOLUMINALTREATMENT OF SAPHENOUS
VEIN INSUFFICIENCY IN A STANDARDIZED EX VIVO MODEL
Introduction—Aim of Study:
The aim of endoluminal thermal procedures is a controlled damage to the vessel wall, resulting in an irreversible
occlusion of the insufficient saphenous vein. To allow experimental evaluation of these procedures, it was
necessary to develop a standardized model. The purpose of the model was to provide an initial comparison of
occlusion procedures in current use.
Materials/Methods:
Acow’s foot contains a subcutaneous vein large enough to treatwith instrument systems currently in clinical use.
The veins (20 cm) from 10 freshly slaughtered cows (18–24months of age, weight 550–650 kg, right hind leg) were
reperfused in situwith blood under standardized conditions at room temperature and subsequently treatedwith
radiofrequency (nZ5) and endoluminal laser energy (nZ5) according to clinical parameters. The Closurew
System with 6F Catheter (VNUS Medical Technologies, San Jose, USA) was used for radiofrequency treatment.
The treatmentwas controlled by a generator, continually retracting the catheter at a rate of 3 cm/min at 85 8C. The
endoluminal laser therapy was performed with a 980 nm diode laser with 600 mm Bare Fiber System (CERALAS
D15ELVeS,CeramOptecGmbH,Bonn,Germany). The laser energywas appliedby interval illuminationwith 7 W
and a pulse duration of 1.5 s (10.5 J) 3 mm apart. Energy levels of 35.7 J/cm and a laser fluence of 22.7 J/cm2 was
reached. After treatment, the veins were subjected to a systematic macroscopic and histological analysis.
Results:
Itwaspossible to reproduce theapplicationof endoluminal thermal energy inall of the specimensunder thedefined
conditions. The radiofrequency device and the laser fiber tips showed various degrees of carbonized material
deposits after treatment.After radiofrequency treatment, therewas nomacroscopic evidence of any thermal lesions
other than a discrete induration of the vessel wall and contraction of the vessel lumen as well as a whitish
discoloration of the endothelium. After laser treatment, localized carbonized lesions of the vessel wall were visible.
After 12–24 exposures these lesions regularly took on transmural form, causing complete perforation of the wall.
Conclusions:
The cow’s foot is suitable as an ex vivomodel for standardized experimental evaluation of endoluminal procedures.
While the endoluminal radiofrequency treatment resulted in a constant, reproducible thermal lesion, it appears
advisable to modify the laser treatment in order to avoid the observed perforations of the vessel wall.
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Delis K, Knaggs AL
Mayo Clinic, Division of Vascular Surgery, Rochester, MN, USA and St Mary’s Hospital,
Imperial College School of Medicine, London, UK
4 Abinger Court, 34-36 Gordon Road, Ealing W5 2AF, London, UKEJVES Extra Vol 11, April 2006
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HAEMODYNAMIC QUANTIFICATION AND CLINICAL SIGNIFICANCE
Introduction—Aim of Study:
A large tortuous vein coursing the back of the kneemay give rise to a constellation of varicose veins, unrelated to
the Great[GSV] or Small[SSV] saphenous veins. Designated popliteal fossa vein[PFV], it perforates the deep
fascia and empties into the deep system. We determined the prevalence, anatomic patterns of reflux, and
haemodynamic and clinical significance of the PFV.
Materials/Methods:
This is cross-sectional controlled study, consisting of 818 limbs (543 patients) stratified according to the presence
[GroupA] or absence [GroupB] of a PFV. Recruits underwent CEAP and VCSS stratification prior to duplex
scanning. VCSS and VSDS scores in GroupA were compared to those of controls [GroupC, nZ24] matched for
CEAP clinical class, age and sex. PFV flow was quantified with reproducible duplex software as previously
reported (Delis KT, Thrombosis and Haemostasis 2004).
Results:
The prevalence of PFV (24/818 limbs) was 2.93% (95% CI: 1.78–4.09%). Afflicted were 12 males and 12 females,
aged 23–82 years, median 54; CEAP clinical status 15!C2, 5!C3, 2!C4, 1!C5, 1!C6. Proximal and distal
reflux (combined) affected 91.7% of limbs in GroupA and 54.5% in GroupB (p!0.001). Overall superficial (100%),
perforator (87.5%) and complex-pattern (41.7%) reflux occurred more often in GroupA (all, p!0.01).
Incompetence in GSV (75%), posterior arch, postero-medial, and small saphenous tributaries was also more
frequent in GroupA (all, p!0.05). SSV reflux in GroupA (29.2%) matched GroupB. The PFV terminated at the
popliteal vein in 96% of cases, proximal to the SSV [median difference 1.5 cm (95% CI: 0.5–2)]. The odds ratio of
a PFV in prior SSV junction surgery was 5.68. Deep venous reflux was evenly distributed in GroupA (41.7%) and
GroupB (27%). The prevalence of incompetent perforators was 283% (95% CI: 194–373) in GroupA and 96% (95%
CI: 95–98) in GroupB (p!.001). PFV tributaries were distributed at the popliteal area (100%); posterior (87.5%),
medial (62.5%), and lateral (37.5%) upper calf and posterior distal thigh (16.7%). The VCSS (median 4, range
2–15) and VSDS (median 2.75, range 0.5–8) scores in GroupAwere both significantly higher than those in GroupC
(p!0.05). Venous reflux haemodynamics at the PFV (median values) after release of manual compression in
the dependent position were as follows: peak velocity 25.5 cm/s; mean velocity 9.46 cm/s; time to peak
velocity 0.2 s; pulsatility 2.7; diameter 0.527 cm; volume flow 167 ml/min; reflux volume 11.1 ml; reflux
duration 5.6 s.
Conclusions:
The PFV (prevalence 2.93%) was present in limbs with complex patterns of reflux, involving all venous systems,
both proximally and distally. The PFV perforated the popliteal fascia to terminate at the popliteal vein, above the
SSV termination. Afflicted limbs had a higher propensity for reflux at the GSVand its tributaries, and three-times
as many incompetent perforators as limbs without a PFV. This mirrored the significantly higher VCSS and VSDS
scores compared to the controls, matched for CEAP clinical class, age and sex. Being haemodynamically similar
to or worse than severely impaired perforator veins, the PFV was associated with extensive varicose veins
distributed at the upper calf. In light of these findings the presence of a VPF warrants investigation.
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RESULTS OF EXTERNAL VENOUS VALVE PLASTY (EVVP) IN PATIENTS WITH
Introduction—Aim of Study:
The aim of this study was to evaluate the patency of EVVP and its effect in symptom relief, ulcer healing and
ulcer-free period in patients with PCVI.EJVES Extra Vol 11, April 2006
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Between 1993 and 2004, 1800 patients with CVI were evaluated and seventeen with PCVI were selected for
EVVP. They were all investigated with ambulatory venous pressure measurement (AVP), colour duplex
ultrasound (CDU), venography and descending-videovenography. The CEAP classification was used to group
the patients.
Table 1.Clinical N Deep reflux AVP mmHg Single plasty Multistation-plastyEJVES Extra Vol 1Multi-levelC4 6 6 72 2 4 2
C5 4 4 80 1 3 2
C6 7 7 85 1 5 6For statistical analysis we used 2!2 frequency tables and Kaplan–Meier survival curves.
Results:
All procedures were technically successful. The healing ulcer rate was 4/7 (57%) within 3 months. All
C4 patients experienced symptom improvement postoperatively and had a recurrence free period of median
72(60–122) months. The C5 group had an ulcer free period of median 61 months (12–72) and the C6 of median
48 (12–72) months.
Postoperatively the AVP reduction was greatest in the C6 group, median 35 mmHg (20–65).
Single plasties (4) had a patency of median 48 months (12–72), 12 multistation plasties (several repairs at the
same level) median 78 months (63–122) and 10 multilevel repairs median 54 months (12–96).
Multistation repairs performed on the C4 group seemed to yield the longest durability with a median of 103
months (84–122).
Conclusions:
Discussion: Adhering to welldefined selecting criteria there was indication for EVVP in approximately 1% of the
referrals. Due to the small size of the material our results did not reach statistical significance and, therefore, we
are cautious in drawing any definite conclusions.
EVVP with an ulcer-healing rate of 57% and satisfactory symptom improvement seems to be an alternative of
surgical treatment for selected patients with PCVI. The durability of this technique seems to be related to clinical
severity and the multiplicity of repairs.
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INCREASED INCIDENCE OF CEREBRAL CLAMPING ISCHEMIA DURING EARLY CONTRALATERAL
CAROTID ENDARTERECTOMY
Introduction—Aim of Study:
The status of the contralateral internal carotid artery (ICA) as a predictor of the need of shunting during carotid
endarterectomy (CEA)has been extensively investigated.However, no studyhas specifically addressed this issue in
patients undergoing stagedbilateral CEA. The aimof our studywas to assess the influence of previous contralateral
CEA and of the timing of the procedures on cerebral clamping ischemia during the second operation.
Materials/Methods:
Between January 2001 and December 2004, 2401 CEAs were performed in 2077 patients in our Center. We
reviewed 251 patients who had bilateral carotid stenosisR70% at the time of the first admission and underwent
staged bilateral CEA. All patients had preoperative duplex scanning and an additional examination before
operation on the second side. Surgery was performed under locoregional anesthesia and systemic blood1, April 2006
ESVS Abstracts—200560pressure was kept in excess of 150 mmHg during carotid artery crossclamping. Carotid shunting was used
selectively in patients who developed neurologic symptoms.
Results:
Twenty-two patients (8.8%) required carotid shunting during the first procedure and 28 (11.1%) during the
second one. Of these, nine were shunted also during the first CEA while 19 tolerated crossclamping during
the first operation. Contralateral CEAs were performed within a median interval of 29 days (range 13–96).
Among the patients who underwent contralateral CEA within 30 days, 23/146 (15.8%, 95% CI 10.4–22.9%)
required carotid shunting; of those undergoing contralateral CEA between 31 and 60 days, 4/73 (5.5%, 95% CI
1.8–14.2%); and of those undergoing contralateral CEA after 61 days, 1/32 (3.1%, 95% CI 0.2–18.0%). The chi-
square for trend was statistically significant (pZ.009). Patients operated on the second side within 30 days had a
nearly fourfold risk (Odds Ratio 3.7, 95% CI 1.3–13.0) of shunting during the second procedure compared to
patients operated after 31 days or more. The highest risk of cerebral clamping ischemia was observed in patients
who needed carotid shunting during the first operation, and underwent the second CEAwithin 30 days (9/18, or
50%, 95% CI 26.8–73.2%).
Conclusions:
These data show an increased incidence of cerebral clamping ischemia during contralateral endarterectomy
performed within 30 days, while after longer intervals between CEAs the need for shunting is significantly
reduced, suggesting a delayed cerebral hemodynamic improvement after unilateral revascularization in
patients with bilateral high-grade carotid stenosis. This phenomenon could be possibly related to a severely
impaired autoregolatory vasoreactivity.
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STATINS SIGNIFICANTLY INHIBIT MATRIX METALLOPROTEINASE EXPRESSION IN CELLS DERIVED
FROM CAROTID ATHEROSCLEROSIS AT HIGHER DOSE CONCENTRATIONS THAN CURRENTLY
PHYSIOLOGICALLY DELIVERED
Introduction—Aim of Study:
In addition to lipid lowering, statins may also reduce adverse cardiovascular event incidence by the induction of
favorable changes in plaque composition. We investigated this by examining the effect of statins on matrix
metalloproteinases (MMPs) that have been previously suggested to influence atherosclerosis and plaque stability.
Materials/Methods:
Cells were isolated from carotid endarterectomy specimens and cultured in the presence or absence of
simvastatin, and vehicle. MMP production and cytokine production were assessed by ELISA: MMP-2, MMP-3,
MMP-8 and MMP-9, Il-6, Il-8, and VEGF. Viability was monitored using MTT (3-(4,5-dimethyl-2-yl)-2,5-
diphenyltetrazolium).
Results:
In the absence of extrinsic stimulation, atheroma cell cultures from carotid endarterectomies displayed a
spontaneous MMP and cytokine production. Mean production of MMP-2, MMP-3, and MMP-9 were,
respectively, 129.7G27.27, 4.592G3.972, and 65.68G59.25 ng/mL at 48 h. Mean production of IL-6 and Il-8 was
21759G30419 and 102094G158882 pg/mL at 48 h in culture. Production of all MMPs increased steadily in
culture up to day 5. A significant but differential dose-dependent inhibition of MMP production by simvastatin
was observed. At 48 h, MMP-3 production was inhibited by 92% at 100 mM, 90% at 50 mM, 79% at 25 mM, 69% at
10 mM, 37% at 1 mM, and 28% at 0.1 mM and 29% at 0.001 mM (P!0.001; ANOVA). MMP-9 was also significantly
inhibited in a similar dose dependent manner, however, MMP-2 and -8 were not even at high doseEJVES Extra Vol 11, April 2006
ESVS Abstracts—2005 61concentrations. Il-6 but not Il-8 production also responded similarly. No changes in cell viability were observed
with simvastatin or vehicle.
Conclusions:
In this model statins demonstrate differential inhibition of MMP production but achieve this effect at much
higher concentrations than currently physiologically delivered. This direct inhibition may be an avenue for the
pleotropic effects of statins and may in future necessitate more potent statin formulations to achieve this
physiologically. Current study in this model includes a comparison of symptomatic and asymptomatic plaques
and an assessment of gene expression using RT-PCR analysis.
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Fig. 1. Production of all MMPs increased steadily in culture up to day 5, as shown in the above example for MMP3.
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Fig. 2. Dose-dependent inhibition of MMP-3 production by Simvastatin. A representative experiment is shown above. MMP-9 was also
inhibited in a similar dose dependent manner.13
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TOTAL OCCLUSION OF THE COMMON CAROTID ARTERY: A MODIFIED CLASSIFICATION AND ITS
CLINICAL RELEVANCEEJVES Extra Vol 11, April 2006
ESVS Abstracts—200562Introduction—Aim of Study:
To investigate the haemodynamics and clinical presentation of common carotid artery occlusion (CCAO) in
patients who were first evaluated for suspected carotid artery disease having total CCAO as detected by color
duplex imaging (CDI).
Materials/Methods:
We reviewed 6415 patients who underwent CDI evaluation performed over a 7-year period. In cases with
CCAO, medical records were reviewed focusing on haemodynamic patterns of the disease under consideration
and their relation to the patients’ clinical status.
Results:
Thirty-five (0.5%) cases met the CDI criteria for CCAO. In the same databank 180 patients (2.8%) had isolated
internal carotid artery occlusion (ICAO), while eight (0.1%) had isolated external carotid artery occlusion
(ECAO). Twenty-nine out of 35 patients (83%) had at least one patent distal vessel. In contrast, cerebral
angiography failed to demonstrate patency in 19 of those patients. The Table shows the CDI classification of
CCAO according to distal vessel patency.
CDI classification of CCAO according to distal vessel patencyOcclusion typeEJVES Extra Vol 11, April 200Patency of distal vessels6Cases (nZ35) %Type I Patent ECA and ICA 10 29
IA Flow direction from ECA to ICA 6
IB Flow direction from ICA to ECA 4Type II Isolated patent ECA 18 51
Type III Isolated patent ICA 1 3
Type IV Occlusion of both ICA and ECA 6 17CDI, color duplex imaging; CCAO, common carotid artery occlusion; ICA, internal carotid artery; ECA, EXTERNAL carotid artery.
Ten patients (29%) presented with stroke and 20 (57%) with transient ischaemic attacks (TIAs). The incidence
of stroke was higher (pZ0.02) in type IV (50%) vs type II lesions (30%) and in type II vs type I lesions (10%,
pZ0.003). Similarly, TIAs presented more often in type II and IV lesions (pZ0.002).
Blood flow in the vertebral andmiddle cerebral arteries was found antegrade in all cases. On the contrary, the flow
direction in the ophthalmic and anterior or posterior cerebral arterieswas either antegrade or retrograde.However,
only the retrograde flow in the ophthalmic artery was more often associated with type II and IV lesions (pZ0.04).
Conclusions:
CCAO is usually not accompanied by an occlusion of the distal vessels. CDI provides an accurate method for
defining the patency of those vessels. Among the main arteries of the developed collateral circulation, only the
flow direction in the ophthalmic artery may be of clinical value. The proposed CCAO classification correlates
well with the patients’ clinical status and may help to better clarify the outcome of this rare entity.
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INTENSIVE TREATMENT WITH ATORVASTATIN: EFFECTS ON BLOOD AND ATHEROSCLEROTIC
PLAQUE INFLAMMATION IN PATIENTS WITH SEVERE CAROTID ARTERY STENOSIS
Introduction—Aim of Study:
Introduction. Inflammation plays an important role in the progression and complication of the atherosclerotic
plaque. Recent studies demonstrate a stabilizing effect of statins on the plaque, possibly due to their
ESVS Abstracts—2005 63antinflammatory effects, with hopeful clinical applications. Objective. To investigate the in vivo effect on blood
and plaque inflammation in patients with severe asymptomatic carotid stenosis after treatment with high-dose
atorvastatin for 1 month.
Materials/Methods:
We performed 20 carotid endarterectomies in patients with asymptomatic severe carotid stenosis (O70%), who
had been randomized 1 month previously to receive 80 mg/day atorvastatin (group A; nZ11) or as control
subjects (group C; nZ9). We obtained blood samples at the time of randomization and surgery, and we
determined several inflammatorymarkers. Carotid plaque composition was assessed by immunohistochemistry
with quantitative image analysis.
Results:
Results. Both groups were clinically comparable. Patients on atorvastatin significantly reduced their total-
cholesterol (191G10 vs 118G10, p!0.05) and LDL-cholesterol (125G9 vs 63G9, p!0.05) blood levels, with no
changes in the control group.
There was a reduction in the activity of PBMC in patients from group A, with a 90 and 50% reduction in MCP-1
and COX-2 mRNA expression compared with the non-treated group (p!0.05).
Plaques from group A had less macrophage infiltration (2.5G1 vs 9.3G2.4%, p!0.05), and reduced MCP-1 and
COX-2 expression (11G1 vs 24G4 and 16G2.3 vs 34G4.4%, respectively; p!0.05 for both).
Conclusions:
Conclusions. Intensive treatment with atorvastatin significantly decreases blood and atherosclerotic plaque
inflammation in only 1month. These results strongly suggest that the stabilizing effect of statins in humans takes
place very early.
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ILIOFEMORAL DEEP VEIN THROMBOSIS IN CHILDHOOD; DEVELOPING A MANAGEMENT
PROTOCOL
Introduction—Aim of Study:
Iliofemoral deep vein thrombosis (IDVT) in childhood is rare.Having recently treated a small series of patientswith
this problem we set out to design an evidence-based protocol for the management of this condition.
Materials/Methods:
An electronic search of the literature was undertaken. All publications pertaining to IDVT in childhood were
analysedmanually and then categorised according to their level of evidence. Recommendations were thenmade
on the basis of this.
Results:
Fifty-two papers were identified in the literature. The commonest presenting symptoms were pain and swelling
in the affected limb (evidence level 2). Predisposing risk factors of special significance in children included the
recent use of venous access device, malignancy, prothrombotic disorders, infection, surgery and congenital
venous anomalies (evidence level 2).
The most frequently described imaging modalities were compression B-mode ultrasonography, Duplex
ultrasonography, venography, and helical CT (evidence level 3).EJVES Extra Vol 11, April 2006
ESVS Abstracts—200564The mainstay of treatment is anticoagulation with LMWH alone or followed by warfarin (evidence level 1).
Early clot removal through catheter-directed thrombolysis or surgical thrombectomy has been shown to be
beneficial (evidence level 2/3). There is little evidence for the benefit of early mobilisation and compression
therapy in childhood.
Conclusions:
Level-1 evidence relating to IDVT in childhood is sparse. The possibility of IDVT should be considered when
examining a child with a swollen and painful limb. Imaging should be with Duplex ultrasound, followed by
spiral CT to include assessment of the IVC. A thrombophilia screen should be taken prior to anticoagulation
with LMWH (and warfarin). Thrombolysis should be considered in cases of extensive IDVT if they presentn
within 14 days of thrombus formation.
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CONCOMITANT VEIN INJURY; LIGATE OR REPAIR
Introduction—Aim of Study:
Few literatures described the impact of associated vein injury in the setting of extremity arterial injury, to study
the effect of venous injuries on the survival of the limb after civilian vascular trauma this prospective study was
designed in which statistical relevance of venous injury on limb survival were calculated.
Materials/Methods:
During the period from January 2000 to June 2003, Due to variousmechanisms of civilian trauma, 71 patientswith
combined arterial and venous extremity trauma were enrolled, 63 males and eight females. Further division into
group I (14patients) inwhichdecision for 1ry amputationwas takendue to severelymangled extremity andgroup
II (57 patients) in which trial for limb salvage was performed which further subdivided into repair group (34
patients) and ligated group (23 patients). Repair included various techniques including, lateral venorrhaphy, E–E
venorrhaphy, interposition vein grafts and venous segment transposition. Auxiliary techniques included
temporary shunts placements and fasciotomy. Secondary amputation was performed in nine patients (five in
repair group and four in ligated group) yet with tendency to survival in repaired popliteal vein injury victims.
Results:
Crude limb salvage was 46/57 (80.7%) with further analysis of the results using Multiple Logistic Regression
Analysis of SSPS version 11.5 for windows showed that the mere presence of vein injury increased the potential
for limb loss after vascular extremity trauma (PZ0.0001) and popliteal vein ligation and to a lesser extent
superficial femoral vein ligation increase the potential of limb loss (PZ0.005 and 0.03), respectively.
Conclusions:
We recommend attempt at vein repair especially if popliteal or superficial femoral veins are involved, yet that
should not be proceed without tight control over the patient’s hemodynamic status.
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HEREGULIN, CYSTEINE RICH-61AND MATRIX METALLOPROTEINASE 9 EXPRESSION IN HUMAN
CAROTID ATHEROSCLEROTIC PLAQUES: RELATIONSHIP WITH CLINICAL DATAEJVES Extra Vol 11, April 2006
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Heregulins (HRGs) are a group of polypeptide growth factorswhich appears to induce neoangiogenesis promoting
the expression of angiogenetic factors such as Cysteine Rich-61 (CYR61). The aim of this study was to evaluate the
potential impactofHRGandCYR61oncarotidplaquedestabilisation in associationwithmatrixmetalloproteinase 9
(MMP-9) production and to determine the relationship of the expression of these factors in carotid plaque with the
degree of carotid stenosis, presence of symptoms, presence of an infarct in CTscan, and carotid plaquemorphology.
Materials/Methods:
Ninety formalin-fixed, paraffin embedded specimens of human carotid atherosclerotic plaque obtained by
endarterectomy. Fifty-three patients (63%) were symptomatic and 37 (37%) asymptomatic. The expression of
HRG, CYR61 and MMP-9 were examined by an avidin–biotin immunoperoxidase technique using specific
monoclonal antibodies against these molecules. We used a scale for the estimation of their expression, in which
negative expression was indicated by 0, weak expression (C) by 1, and the strong expression (CC orCCC)
by 2. In serial sections we also determined the cellular phenotype of atherosclerotic plaques, i.e. the endothelial
cells, macrophage and smooth muscle cells. Differences between variables were examined by chi-square test and
correlations by Kendall’s tau non-parametric coefficient.
Results:
There was a positive correlation among HRG, CYR61 and MMP-9 (p!0.01). More than half of specimens
producing greater than 90% stenosis had an intense expression of Cyr61 (p!0.05), while no differences were
observed in Cyr61 expression among the other studied variables. Similarly, HRG expression was higher
regarding to the degree of carotid stenosis and moreover, there was a significant difference in HRG expression
regarding to plaque morphology (p!0.05). The expression of MMP-9 was found higher in tighter stenosis, in
complicated plaques and when there was a cerebral infarct in CT scan (p!0.05).
Conclusions:
There were evidences that HRG, CYR61 involve in plaque neovascularization and progression but they were not
associated with symptoms. MMP-9 and HRG, however, may have a relationship to complicated plaque
development.
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FEMORAL-FEMORAL CROSSOVER BYPASS—A RANDOMISED CONTROLLED MULTICENTRE TRAIL
COMPARING TWO GRAFT MATERIALS
Introduction—Aim of Study:
To investigate whether a fluoropassivated polyester graft was comparable to a PTFE graft for femoro-femoral
cross-over bypass.
Materials/Methods:
A multicenter (nZ10) randomised controlled trial enrolled 198 patients, who had a femoro-femoral crossover-
bypass. Patients were randomised to receive either an 8 mm PTFE graft (nZ107) or an 8 mm fluoropassivatedEJVES Extra Vol 11, April 2006
ESVS Abstracts—200566polyester graft (nZ91). The two groups were similar with respect to age, gender, risk factors and symptoms.
Two-thirds were operated on for claudication, while 27% suffered ischaemic rest pain and 10% had tissue lost.
Patients were scheduled for 1, 12 and 24 months follow-up.
Results:
Primary patency rates for PTFE and fluoropassivated polyester grafts were 0.93 (95%-confidence interval:
0.88–0.93) and 0.89 (0.83–0.96) at 12 months and 0.93(0.86–1.00) and 0.87(0.77–0.97) at 24 months. This
difference was not significant (log-rank: pZ0.35). After 12 and 24 months 75 and 77% had become
asymptomatic, respectively. Ankle-brachial index increased from 0.41(0.30–0.54) (median and interquartile
range) preoperatively to 1.20(0.95–1.40) and 1.20(0.90–1.40) at 12 and 24 months, respectively.
Conclusions:
In patients with unilateral iliac artery disease not amenable to PTA, the femoral-femoral bypass is an excellent
alternative to the aorto-bifemoral graft. These results disprove the generally held view that claudicants are not
candidates for femoral-femoral crossover bypass surgery.
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NANO-COMPOSITE(S) CONTAINING BIOACTIVE PEPTIDES PROMOTES ENDOTHELIALIZATION OF
CARDIOVASCULAR BYPASS GRAFTS BY CIRCULATING ENDOTHELIAL PROGENITOR CELLS:
AN IN VITRO EVALUATION
Introduction—Aim of Study:
The formation of an endothelial cell layer on the luminal surface of cardiovascular bypass grafts is an important
goal in order to improve their patency rates. Endothelial progenitor cells (EPCs) have a potential role in
endothelialization of bypass grafts. We hypothesized that a novel approach to improve bypass grafts
endothelialization by EPCs would be by creating on their luminal surface a microenvironment that supports
EPCs’ adhesion and differentiation.
Materials/Methods:
Anewgeneration of nano-composite,which incorporates bioactive peptides,wasmade into sheets. EPCs isolated
from consented adult volunteers were then plated both on these sheets and also on sheets of the nano-composite
without the bioactive peptides and finally on uncoated dishes and then cultured in presence of vascular
endothelial growth factor (VEGF). Confirmation of endothelial and EPCs markers was carried out using
fluorescence-activated cell sorter (FACS), reverse transcription polymerase chain reaction (RT-PCR) and
immunostaining.
Results:
One to two percent of peripheral blood mononuclear cells (PBMCs) expressed CD34 as determined by FACS
analysis. Cells were demonstrated to express mRNA for the EPC markers CD34, platelet-endothelial cell
adhesion molecule-1 (CD31), CD133, and vascular endothelial growth factor receptor-2 (FlK-1/KDR).
Endothelial cells-colony forming units were formed between day 5 and 7 after plating. Colonies were
confirmed to be EPCs by immunostaining with the use of antibodies directed against eNOS, vWF, and CD31.
There were significantly greater numbers of EPC colonies, which appeared on the bioactive-containing nano-
composites as compared to the nano-composite without the bioactive peptides and the uncoated dishes.EJVES Extra Vol 11, April 2006
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We report a new biomaterial that has been demonstrated, in vitro, to promote endothelialization from circulating
EPCs. Studies are now undergoing to see whether this material can self-endothelialize under physiological flow
and in vivo.
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THE ROLE OF HYPOXIA IN THE AETIOLOGY OF ABDOMINAL AORTIC ANEURYSM
Introduction—Aim of Study:
Increased matrix metalloproteinase (MMP) activity leads to aneurysm through degradation of the collagen and
elastin matrix that provide the aortic wall integrity. Upregulation of MMP-2 is significant in the initiation of
abdominal aortic aneurysms (AAA) and subsequently MMP-9 is implicated as the major destructive factor in
larger aneurysms (Freestone et al.Arteriosclerosis Thrombosis, 1995;15:1145–51). Aortic wall pO2 is known to be
lower in aneurysmal aorta compared to normal (Vorp et al. J Vasc Surg, 2001;34(2):291–9). This study explores the
induction of active MMP-2 by hypoxia in human AAA tissue.
Materials/Methods:
Proximal, body and distal regions of the aneurysm sac were isolated from 41 patients undergoing elective AAA
repair. Immunohistochemistry using anti-human MMP-2, MMP-9 and hypoxia-inducible factor 1&#945; (HIF-
1&#945;) was performed on 5&#956;m serial wax sections. Vascular smooth muscle cells (VSMC) were isolated
from normal human aorta and exposed to various levels of hypoxia over 72 h. Secreted MMPs were quantified
using zymography with densitometric analysis.
Results:
Results show localisation of MMP-2 to the region of tunica media distant from the vasa vasorum. Analysis of the
three aneurysmal regions revealed MMP-2 concentrated to the body of the sac; gelatin zymography confirmed
MMP-2 levels highest in homogenates from same region. Analysis shows a significant increase in HIF-1&#945;
positivity for AAA tissue when compared with normal aorta, with localisation to the same regions as MMP-2.
Conclusions:
The finding of MMP-2 and HIF-1&#945; at sites furthest from the source of oxygen (vasa vasorum) strongly
suggests hypoxic activation. A role for hypoxia is further strengthened by the finding that MMP-2 is secreted in
highest levels from hypoxic VSMC and HIF-1&#945; co-localises with high expression of MMPs. Further work is
ongoing to elucidate the role of hypoxia and HIF-1&#945; in MMP-2 upregulation with a view to identifying a
potential target for therapeutic intervention.
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HAEMOGLOBIN A1C (HBA1C) IN NON-DIABETIC VASCULAR PATIENTS, IS HBA1C AN INDEPENDENT
RISK FACTOR AND PREDICTOR OF ADVERSE OUTCOME?
Introduction—Aim of Study:
Diabetic patients with HbA1cO7% have increased risk of microvascular andmacrovascular complications. Our
aim is to determine if elevated plasma HbA1c level was associated with adverse outcome in non-diabetic and
diabetic patients undergoing vascular procedures. Our primary endpoint is postoperative morbidity and
mortality and secondary endpoint is length of hospital stay.EJVES Extra Vol 11, April 2006
ESVS Abstracts—200568Materials/Methods:
Plasma HbA1c was measured prospectively in 157 consecutive patients over a 6-month period. Clinical data
was entered into a prospectively maintained database (VascuBase). Non-diabetic patients were further stratified
into two groups, plasma HbA1c level &#61603; 6.0% (normal) orO6.0% (abnormal). Diabetic patients were also
divided, plasma HbA1c level &#61603; 7.0% (normal) orO7.0% (abnormal). Two tailed t-test and multivariate
analysis were performed for statistical analysis.
Results:
One hundred and seventeen patients (74.5%) were non-diabetic. Overall mean age was 72 years and 59.4% were
male. Abnormal HbA1c levels were found in 59.8% non-diabetic and 47.5% diabetic patients. In non-diabetic
patients, those with abnormal HbA1c had a significantly higher complication rate (6.25 vs 23.4%, pZ0.001) than
those with normal HbA1c. In diabetic patients, those with abnormal HbA1c had a significantly longer length of
hospital stay (20 vs 37 days, p!0.001) and higher complication rate (8.3 vs 32.6%, p!0.05) than those with normal
HbA1c. Multivariate analysis demonstrated that elevated HbA1c is a significant independent predictor of
adverse post-operative outcome in both non-diabetic and diabetic patients. Abnormal HbA1c did not have a
significant effect on mortality.
Conclusions:
A significant proportion of non-diabetic patients undergoing vascular surgery have abnormal HbA1c. HBA1c
level of 6.1–7% was a significant independent predictor of increased length of stay, stroke, myocardial infarction,
amputations and mortality after vascular surgical procedures in non-diabetic patients. Diabetic patients with
abnormal HbA1c have increased length of hospital stay. Tighter diet control and pharmacological manipulation
are mandatory.
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SMOOTH MUSCLE DYSFUNCTION IN ATHEROSCLEROTIC DISEASE
Introduction—Aim of Study:
Patients with abdominal aortic aneurysm and peripheral arterial occlusive disease are associated with high risk
for cardiovascular disease and short life expectancy. Smooth muscle as well as endothelium may participate in
the clinical condition of atherosclerotic disease. However, ultrasonographic evaluation of smooth muscle
function, nitroglycerin (NTG)-mediated vasodilatation, remains to be clarified. Furthermore, value of brachial
ultrasound test in these advanced atherosclerotic diseases has yet to be revealed.
Materials/Methods:
Brachial artery flow-mediated vasodilatation (FMD) and NMD were measured in 64 patients with
atherosclerotic disease (AAA/PAODZ34/30, mean age 71.6G7.6 years, range 54–86). FMD was recorded for
5 min and NMDwas recorded for 15 min on super-VHS for analysis. Brachial diameter responded to hyperemia
and NTG were measured every 1 min after deflation or NTG administration. Insulin, fasting blood sugar, total
homocysteine, asymmetric dimethylarginine, advanced glycation end products, highly sensitive CRP,
adiponectin and IMT of the brachial artery, carotid maximal IMT, blood pressure were measured. Homeostasis
model assessment of insulin resistance (HOMA-IR) was calculated.
Results:
In 64 atherosclerotic patients, response to NTG showed sigmoid curve, and 89% of patients reached maximal
diameter at 6 min or later. On multiple regression analysis, higher FMD was associated only with higherEJVES Extra Vol 11, April 2006
ESVS Abstracts—2005 69NMD (P!0.001). Higher NMDwas associated with smaller vessel size (P!0.001), lower systolic blood pressure
(P!0.001), higher FMD (P!0.001), lower carotid maximal IMT (PZ0.001), lower serum levels of insulin
(PZ0.012), and lower HOMA-IR (PZ0.027).
Conclusions:
NMD measured at 3 or 4 min after NTG administration would underestimate smooth muscle function. NMD
measured with maximal responded diameter was associated with atherosclerotic risk factors. With regard to
value of brachial ultrasound test, maximal NMD may have an important meaning in advanced atherosclerotic
disease.EJVES Extra Vol 11, April 2006
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DUPLEX GUIDED BALLOON ANGIOPLASTYAND STENT PLACEMENT FOR FAILING INFRAINGUINAL
BYPASS GRAFTS: A NEW APPROACH TO ELIMINATE OR MINIMIZE RADIATION EXPOSURE AND
NEPHROTOXIC CONTRAST MATERIAL
Introduction—Aim of Study:
Salvage of failing infrainguinal bypasses by endovascular techniques has been shown to effectively improve
patency and limb salvage results in selected cases. These require the use of contrast arteriography and
fluoroscopy. We attempted to perform balloon angioplasty and stent placement under duplex guidance to avoid
or minimize the use of nephrotoxic contrast material and radiation exposure.
Materials/Methods:
Over the last 15months, 25 patients (72%males) with amean age of 76G8 years presented to our institutionwith a
failing infrainguinal bypass. Hypertension, diabetes, renal insufficiency, coronary artery disease and smokingwere
present in 77, 69, 54, 42 and 38%of cases, respectively. A total of 31 attempted balloon angioplasties (26 vein; 5 PTFE)
were included in this study. Twenty-two vein grafts were common femoral artery (CFA) to popliteal (9) and
infrapopliteal (13) bypasses and fourwere popliteal to popliteal (1) and infrapopliteal (3) bypasses. Of the five PTFEEJVES Extra Vol 11, April 2006
ESVS Abstracts—2005 73grafts threewereCFA topopliteal (1) and infrapopliteal (2) bypasses and the remaining twowere superficial femoral
artery to popliteal bypasses. In 18 cases there was a single stenosis and in the remaining 13 cases there were 2–5
stenoses (mean 1.3G1.1 stenoses). The site of the most significant stenotic lesion was at the inflow in four cases,
conduit in 18 cases and at the outflow in nine cases.
All arterial (20) or graft (11) entry sites cannulationswere done under direct duplex visualization. Duplex scanning
was the sole imagingmodality used tomanipulate the guidewire andguiding catheters from the ipsilateralCFA toa
site beyond the most distal stenotic lesion. Selection and placement of balloons and stents were also guided by
duplex. In 10 cases (32%) the contralateral CFAwas used as the entry site and a standard approach (fluoroscopy and
contrast material) was employed to reach the ipsilateral CFA. Completion duplex examswere obtained in all cases.
Results:
The overall technical success was 97% (30/31 cases). In only one case the stenotic lesion could not be traversed
with the guidewire. Complications included two arterial dissections of the inflow arteries treated successfully
with stents, one outflow pseudoaneurysm repaired by patch angioplasty and one puncture site
pseudoaneurysm that required open repair. Overall 30-day survival rate was 100%. Overall 6-month limb
salvage and primary patency rates were 100 and 64%, respectively.
Conclusions:
The proposed technique appears to be an effective modality for the treatment of failing infrainguinal arterial
bypasses. Advantages include direct visualization of the puncture site, accurate selection of the proper size
balloon and confirmation of the adequacy of the technique by hemodynamic and imaging parameters.
Additional benefits are avoidance of radiation exposure and contrast material in most cases.
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EXPRESSION OF GROWTH FACTORS AND GROWTH FACTOR RECEPTOR IN NON-HEALING AND
HEALING ISCHAEMIC ULCERATION
Introduction—Aim of Study:
Peripheral vascular disease (PVD) is a serious and common condition faced by health care delivery systems.
PVD contributes to 20% of all lower limb ulceration and is present in isolation in about 10% of cases. Despite
being the gold standard treatment for non-healing ischaemic ulcers, little is known about the underlying
mechanism by which revascularised chronically ischaemic ulcers re-epithelialise. Our aim was to characterise
the histological and cytokinetic characteristics of purely ischaemic ulcers and the processes that underpin
healing following successful revascularisation.
Materials/Methods:
Biopsies were taken immediately pre- and 6 week’s post-revascularisation, incorporating surrounding skin,
ulcer edge and base. They were evaluated for morphological changes by H&E and for growth factor (GF) and
growth factor receptor (GFR) expression using immunohistochemistry. Localisation and quantification of
platelet derived growth factor receptor (PDGFR), epidermal growth factor receptor (EGFR), transforming
growth factor beta 1 and 3 (TGF&#946;1 and TGF&#946;3) and von Willebrand factor (vWF) were examined
systematically by three independent investigators who were blinded to the timing of biopsy.
Results:
Preoperatively there was small vessel vasculitis, necrosis and infection with a profuse neutrophil andmacrophage
infiltrate in all samples. Postoperative biopsies revealed a proliferation of new, small blood vessels in the
surrounding skin, particularly in and around the ulcer edges and base. Overall, there was less infection and
inflammationwithminimal vasculitis. Accelerated epithelial proliferationwas observedwith detachment from the
underlying dermis. These findings correlated with increased staining for PDGF receptor localised to fibroblastsEJVES Extra Vol 11, April 2006
ESVS Abstracts—200574and prominent staining for TGF&#946;3, PDGF receptor and TGF&#946;receptor3 localised to areas of
neovascularisation. vWF staining confirmed an endothelial lining within these new vessels.
Conclusions:
Healing of purely ischaemic ulcers is by angiogenesis and this process is associated with increased activity of the
proangiogenic cytokines PDGF and TGF&#946;3. These findings show promise for the use of growth factor
manipulation to aid healing in ischaemic ulcers.
25
Kaperonis EA, Liapis CD, Kakisis JD, Dimitroulis D, Papavassiliou VG, Kostakis AG
2nd Department of Propedeutic Surgery, Athens University Medical School, 85, G. Zografou
str., 15772 Athens, Greece
INFLAMMATION AND CHLAMYDIA PNEUMONIAE INFECTION CORRELATE WITH THE SEVERITY
OF PERIPHERAL ARTERIAL DISEASE
Introduction—Aim of Study:
The correlation between inflammation, infection and arterial disease is well known. Our aimwas to investigate the
associationof inflammationandC.pneumoniae infectionwith thepresenceandseverityofperipheral arterialdisease.
Materials/Methods:
Twenty-eight patients whose initial claudication distance (ICD) in the traditional constant-load treadmill test was
!200 m, underwent femoral endarterectomy as part of their interventional treatment (groupA). GroupB consisted
of 23 patientswhose ICDwasO200 mandwere put onmedication and a daily exercise program. The control group
consisted of 30 non-vascular patients of the Ophthalmology Department (Group C). We measured the levels of
C-reactive protein, fibrinogen, vascular cell adhesion molecule-1 and tumor necrosis factor-&#945, and the titers of
IgA and IgG antibodies against C. pneumoniae in the serum of all the patients. Finally, the atheromas and vein
segments of group A patients, were immunohistochemically (IHC) examined for the presence of C. pneumoniae.
Results:
Peripheral arterial disease (PAD) patients had significantly higher CRP (pZ0.026) and anti-Cp IgA levels
(pZ0.001) when compared to control subjects, after a multiple linear regression analysis. The odds ratio for the
prevalence of femoral atherosclerosis was 3.16 for IgA seropositive patients (CI 1.15–8.67). When comparing
group A and group B patients, CRP, fibrinogen, TNF-&#945; and anti-Cp IgA, were significantly correlated with
severe PAD. After multiple analysis though, only CRP (pZ0.003) and IgA (pZ0.011), remained significantly
associated. Group A patients with positive immunohistochemical examination of the plaque, had higher anti-Cp
IgA levels (pZ0.023) and TNF-&#945; values (pZ0.031), compared to the IHC negative patients. C. pneumoniae
was detected in 50% of the femoral atheromas, but in only 3.6% of the veins.
Conclusions:
This study supports the hypothesis that inflammation (CRP) and chronic C. pneumoniae infection (IgA
seropositivity), have an important role in lower limb atherosclerosis and correlate with the severity of the disease.
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NEW MONITORING SYSTEM OF PENILE BLOOD FLOW AND BUTTOCK BLOOD FLOW DURING
ENDOVASCULAR REPAIR OF ABDOMINAL AORTIC ANEURYSM
Introduction—Aim of Study:
Internal iliac artery (IIA) is often occluded as an adjunct to endovascular stent grafting for treating abdominal
aortic aneurysm (AAA) repair (EVAR), and this can be associated with pelvic ischemic morbidity such asEJVES Extra Vol 11, April 2006
ESVS Abstracts—2005 75impotence, buttock claudication, and bowel ischemia. The purpose of this study was to assess the utility of new
methods to monitor pelvic hemodynamics during AAA repair.
Materials/Methods:
We used a recently developed device, form PWV/ABI (Colin Medical Technology, Ltd, Komaki, Japan) to
measure penile blood pressure (PBP) and the penile brachial pressure index (PBI) during AAA repair. We also
measured bilateral buttock tissue oxygenation with near-infrared spectroscopy (NIRS) using the NIRO 300
(Hamamatsu Photonics K.K., Hamamatsu, Japan) to monitor the buttock tissue oxygenation index (TOI), the
ratio of oxygenated hemoglobin to total hemoglobin in tissue. After general anesthesia, an occlusion and
monitoring cuff was placed around the penis. PBP was measured by pulse volume plethysmography.
Two probes of the NIRO 300 were placed on both sides of the buttocks, and the TOI was monitored continuously.
We tested the methods in 10 patients who underwent EVAR.
Results:
In the EVAR, aortouniiliac stent graft with crossover bypass graft was performed with preservation of
contralateral IIA in all of the patients. During malperfuion of IIA (Fig. 1), both PBI and TOI (at stent graft side
and contralateral side) decreased to 62, 21, and 26% of the initial values, respectively, and recovered to the initial
values after the completion of endovascular repair with crossover bypass (Figs. 2 and 3). No clinical sequelae
were seen in any of the patients.
Conclusions:
Both the TOI at the buttocks and the PBI reflect pelvic hemodynamics sensitively. Continuous monitoring of
those indexes during an operation may help in intraoperative planning for intentional IIA coverage by stent
graft with/without external-to-internal iliac artery bypass.Fig. 1.
Fig. 2.EJVES Extra Vol 11, April 2006
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CAN 16-SLICES CT ANGIOGRAPHY BE USED FOR PLANNING TREATMENT OF CRITICAL LIMB
ISCHEMIA IN DIABETIC PATIENTS?
Introduction—Aim of Study:
Digital subtraction angiography (DSA) and sonography are the goal standard diagnostic tests before ankle and
foot revascularization in diabetic patients (DP) with critical limb ischemia (CLI) and infra-popliteal arterial
occlusive disease. DSA is an invasive and expensive test while the accuracy of sonography in multisegmental
peripheral arterial disease and heavy parietal calcifications is low. Non-invasive alternatives for accurate
depiction of tibial and foot arteries are, therefore, desirable.
The aim of our study was to compare 16-slices computed tomographic angiography (CT-A) with DSA in
evaluating tibial and foot arteries disease among DP with CLI.
Materials/Methods:
A prospective study was conducted involving 22 limbs (20 patients, 10 men, mean age 73.5 years) in
diabetic patients (eight insulin therapy) with CLI (three patients Fontaine’s stage III; 19 patients Fontaine’s
stage IV, Texas wound classification: IB-1 patient, IC-10 patients, IIA-1 patient, IIC-5 patients, IIIC-1 patient,
IIID-1 patient) who underwent CT-A and DSA of the peripheral arteries within 5 days from each other
before lower extremity revascularization. Each limb was divided into 23 anatomical segments (external iliac
artery, common femoral artery, superficial femoral artery, deep femoral artery, popliteal artery, anterior tibial
artery, tibio-peroneal trunk, posterior tibial artery, peroneal artery, dorsalis pedis artery, plantar arteries,
plantar arch). Arteries depicted at CT-A and DSA were graded separately for degree of stenosis (a: no
stenosis, b: !50%, c: 50–70%, d: 70–99%, e: 100%). The sensitivity, specificity and accuracy for detection of
significant lesions (stenosisO70%) of CT-A were calculated with findings at DSA used as the reference
standard.
Results:
The CT-A and DSA performed in the 22 limbs produced 1012 arterial segments for evaluation. At DSA, 231
diseased segments (degree of stenosis: d–e) were found. The sensitivity of CT for significant lesions
(stenosisO70%) was 66% for the suprainguinal, 65% for the femoro-popliteal, 77.2% for the calf arteries and
73.5% for foot arteries; corresponding specificity and accuracy were 100, 90.5, 65, 62.3 and 95.4, 81.8, 71.8,
68.2%, respectively. The CT-A accuracy in the detection of d–e lesions of tibial and foot arteries was 72.7%
for the anterior tibial artery, 77.3% for the tibio-peroneal trunk, 78.8% for the posterior tibial artery, 62.1%
for the peroneal artery, 69.7% for the plantar arteries, 54.5% for the dorsalis pedis artery and 77.3% for the
plantar arch.EJVES Extra Vol 11, April 2006
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A review of the data obtained in this series indicates that CT-A appears to be able to replace preoperative DSA
in most DP with CLI found to require femoro-popliteal reconstruction. Patients who are predicted by means of
CT-A to require peroneal artery or pedal arteries revascularization should still undergo preoperative DSA
and/or sonography to confirm these results and to define more precisely the better surgical choice
(endovascular treatment or bypass).
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DOES LINEZOLID IMPROVE PROGNOSIS FOLLOWING VASCULAR RECONSTRUCTION IN MRSA
POSITIVE PATIENTS?
Introduction—Aim of Study:
Methicillin-resistant Staphylococcus aureus (MRSA) is now the commonest single organism cultured in
patients with complex wound and graft infections after vascular surgery. MRSA infection is associated
with a high mortality and lower limb graft infection, with a high rate of limb loss. We examined the effect of
the oxazolidinone, linezolid, a new specific oral anti-MRSA antibiotic, in MRSA infected vascular patients.
Materials/Methods:
Data was analysed for all MRSA Cve patients admitted to the vascular unit over 3 years (August 2001–2004).
These patients were divided into two groups: those treated with linezolid and those who were not. Outcome
measures compared were graft survival, major limb amputation and mortality rates.
Results:
There were162 MRSA Cve inpatients during this period, 34 of whom were treated with linezolid in
addition to vancomycin or teicoplanin. The median period of prescription was 14 days. In the linezolid
group 16/21 (76%) grafts were preserved and 5/21 (24%) were explanted due to infection. In comparison
19/36 (53%) grafts were preserved and 17/36 (47%) were explanted in the non-linezolid group (p!0.05
and p!0.05, respectively; !2 test). In the linezolid group MRSA infection was a direct cause of 6 (18%)
major limb amputations whilst amongst the non-linezolid group there were 31 (24%), p value O0.05.
MRSA infection related mortality was 6 and 9% in the linezolid and non-linezolid groups, respectively
(p value O0.05).
Conclusions:
We have demonstrated statistically significant improvement in graft preservation in those patients treated with
linezolid. Emergence of multi drug-resistant pathogens such as MRSA has made treatment a therapeutic
challenge. Linezolid is a promising antimicrobial agent providing the clinician with an additional treatment
option, with encouraging results in this study. The oral formulation enhances patient and physician
convenience, making it a valuable therapeutic alternative.
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THE NATIONAL HOSPITAL DISCHARGE REGISTER DATA ON LOWER LIMB AMPUTATIONS—QUALITY
INDICATOR FOR DIABETES CARE?
Introduction—Aim of Study:
Aim. To study if data on lower limb amputations in the National Hospital Discharge Register can be used for
comparison of diabetes care between hospital districts. Background: Neuropathy, ulcers and infections in feet
are feared complications of diabetes that can result in amputation of the extremity especially when vascularEJVES Extra Vol 11, April 2006
ESVS Abstracts—200578disease prevents the healing. Good care of diabetes is believed to prevent such adverse consequences and
vascular surgery to decrease amputations.
Materials/Methods:
We identified diabetic persons from the National Hospital Discharge Register in 1988–2002. To this list of
diabetics we added all persons from the register of the National Social Security Institute over persons who got
their anti-diabetic drugs reimbursed since 1964 and all persons to whom anti-diabetic drugs have been delivered
from pharmacies since 1994. More than 308,000 diabetics were identified.
After the identification of diabetic persons we looked for all the amputations of lower extremities of these
persons in the Hospital Discharge Register. The incidence was compared within the hospital districts by
standardizing the numbers with age and gender of the diabetic populations.
Results:
Many patients had several amputations done during this period. We chose to analyse the numbers of
the first amputation of each person. In all, there were 11,331 diabetics who had a lower extremity
amputation during the period. The number of first amputations decreased from 767 to 385 per 100,000
diabetics from 1989 to 2002. Big differences between hospital districts could be seen. Age and gender
adjusted index (proportioned to the diabetic population) during the last follow-up period in 2000–2002
varied from 48 to 140, when the whole country was marked with 100. In the presentation regional maps
will be shown.
Conclusions:
Comparison of the incidence of first amputations of diabetics can be done between the hospital districts. The
figures can be used for planning the health care services for diabetics in order to prevent amputations.
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HYALURONAN-BASED TEMPORARY SCAFFOLD FOR IN VIVO REGENERATION OF SMALL DIAMETER
(2 MM) ARTERIES
Introduction—Aim of Study:
The limited supply of suitable small-diameter vascular grafts has led to the development of tissue engineered
blood vessel substitutes. Many different approaches have been examined, including natural scaffolds containing
one or more ECM proteins and degradable polymeric scaffolds. In all cases, the final aim has been the
remodelling of the starting structure in order to create a biocompatible tissue analogue. To reproduce and
positively guide the remodelling process directly in vivo, we searched a biomaterial functioning only as
temporary absorbable guide to promote the sequential and complete regeneration of vascular structures at the
implantation site.
Materials/Methods:
Hyaluronan-based graft (HYAFF 11e tube, diameter 2 mm, length 2 cm) was used as temporary absorbable
guide to promote the complete regeneration of vascular structures in an animal model. A tube Hyaluronan-
based graft was implanted in an end-to-end fashion in the abdominal aorta of 30 rats. Histological and
immunohistochemical and electron microscopic analysis were used to evaluate the results at 5, 15, 30, 60, 120,
and 180 days.
Results:
At 5th day a new tissue is observed on the graft coming from both proximal and distal end of the aorta. The
luminal surface of the regenerating tissue is covered by endothelial cells (CD34C, VEGFR-2C, vWFC). At 15th
day, regenerating tissues from distal and proximal ends joint at the centre of the tube. A continue endothelial
layer covers the luminal surface of the neo-vessel. Moreover muscle, elastic, and collagen tissues are present inEJVES Extra Vol 11, April 2006
ESVS Abstracts—2005 79the neo-artery wall context. From 30th day to 120th day the regeneration and remodelling processes continue,
ending in a stable neo-artery segment. The biomaterial starts to degrade by the intervention of macrophages and
the resorption process ends after 120 days. Infiltration of neutrophils and linfocytes was never observed at the
different time points. The survival and patency rate was 100% and signs of insufficient vascular perfusion were
never observed in the hindlimbs.
Conclusions:
The hyaluronan-based graft allowed complete regeneration of a newly formed vascular tissue in which all
the cellular and extracellular components are present and organized in a well defined architecture similar
to native tissue. In our rat experimental model, the hyaluran-based graft satisfied the major requirements
of an ideal vascular scaffold: it was provisional, able to permit rapid vascular tissue ingrowths, to
facilitate rapid endothelialization of the luminal surface, and to provide a ‘mechano-active’ environment
in response to pulsatile stress, promoting a new vascular tissue with a compliance similar to native
arteries.
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DIFFERENTIAL PROGRESSION RATES OF ATHEROSCLEROSIS IN CORONARY AND PERIPHERAL
ARTERIES—INDEPENDENT PREDICTORS OF VASCULAR DEATH?
Introduction—Aim of Study:
Peripheral arterial disease is associated with high cardiovascular risk. This may be due to a slower evolution of
peripheral atherosclerosis.
Materials/Methods:
Predefined segments of coronary (LAD, RCA), and bilateral carotid, and superficial femoral arteries (proximal
part) were obtained from 100 autopsies (70 men; 20–82 years, mean age 47.1G14.1); 27 died from coronary
atherosclerosis. The segments were processed for microscopy (w48 sections per subject). The presence of mature
plaque in each segment was recorded. The section with the largest intima (Zplaque) area in each of the six artery
segments was selected for connective tissue staining (nZ600), and the intima area was quantified by blinded
computerized planimetry. To correct for differences in arterial sizes, a relative intima size (RIS) was calculated by
dividing the intima area with the length of the internal elastic lamina. We evaluated the association between
coronary death and presence of plaque using multiple logistic regression analysis with age and sex as the other
independent variables.
Results:
Femoral plaques did not exist without coronary and carotid plaques and occurred later (4th vs 3rd
decades). The odds ratio for coronary death in the presence of femoral plaque was 21.3 (5.0–90.0) with a
receiver operating curve area of 0.72 (0.62–0.81). Coronary plaques were also highly associated with
coronary death while carotid plaques did not contribute to prediction of coronary death. The figure shows
box and whiskers plots of the RIS for ascending decades of age in each vascular territory (for non-coronary
and coronary deaths). The femoral RIS increased much slower in the subjects dying of non-coronary causes
when comparing with other territories. Subjects dying of coronary causes were characterized by a faster
increase of the femoral RIS.Conclusions:
Femoral atherosclerosis develops later and slower than coronary and carotid atherosclerosis. Thus, presence of a
femoral plaque indicates advanced generalized atherosclerosis and high cardiovascular risk.EJVES Extra Vol 11, April 2006
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VIRTUAL REALITY SIMULATION TRAINING CAN IMPROVE INEXPERIENCED SURGEONS’ ENDOVAS-
CULAR SKILLS
Introduction—Aim of Study:
Introduction: It is no longer acceptable or appropriate to learn to perform interventional procedures on real
patients. Recent advances in computer technology have enabled the use of virtual reality (VR) simulators to
teach the skills necessary for interventional vascular procedures. The aim of this study was to evaluate VR
simulation for endovascular training of surgeons inexperienced in this technique.
Materials/Methods:
Methods: Twenty consultant vascular surgeons experienced in open surgical skills were recruited, and
divided into those with endovascular skills (group A O50 procedures, nZ8) or those without (group B
!10 procedures, nZ12). All subjects were familiarised to the Vascular Interventional Surgical Trainer
(VIST, Mentice, Sweden), and performed a non-ostial renal artery balloon angioplasty and stent
procedure. The simulator uses real guidewires and catheters, provides a realistic image of the virtual
patient, and has active force feedback. Surgeons in group A performed three repetitions, and group B
completed six repetitions of the same task, over a 2-day period. Performance was automatically and
objectively recorded by the simulator for parameters such as time taken and amount of contrast fluid
used.
Results:
Results: The experienced surgeons in group A performed to similar levels over the three sessions for time
taken (median 600 s, pZ0.472) and amount of contrast fluid used (19.6 ms, pZ0.779). Inexperienced
endovascular operators in group B made significant improvements in performance between the first and
sixth session for time taken (median 900 vs 456 s, pZ0.021) and amount of contrast fluid used (42.9 vs
19.3 ms, pZ0.007).
Conclusions:
Conclusions: Surgeons with minimal endovascular experience can improve their time taken and contrast usage
during short-phase training on a VR endovascular task. In contrast, experienced operators showed non-
significant improvements. Thus VR simulation may be useful for the early part of the learning curve for
surgeons who wish to expand their endovascular interests.
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STEAL EFFECT IN PATIENTS ON HEMODIALYSIS: DIFFERENCES BETWEEN TYPES OF VASCULAR
ACCESS
Introduction—Aim of Study:
An autogenous arteriovenous fistula (AVF) placed at the wrist (radiocephalic fistula, ‘RC’) is the preferred
method for hemodialysis vascular access. Forearm prosthetic graft loop fistula (‘loop’) placement may be
a second best option, while autogenous brachiocubital fistulas (elbow, ‘BC’) are growing in popularity as an
alternative choice.EJVES Extra Vol 11, April 2006
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symptomatic ischemia. The aim of the present study was to investigate steal effect in three types of
vascular access.
Materials/Methods:
Patients were evaluated by a questionnaire including items as cold sensation, pain and cramps in the
dialysis hand. In addition to physical examination, gripstrength, skin temperature and finger blood
pressure (with open and compressed fistula) were determined. Capillary blood gas, oxygen saturation
and tissue oxygenation (near infrared spectroscopy, NIRS) were also measured. The contralateral arm was
used as a control.
Results:
The questionnaire was completed by 120 patients. In the table the percentage of patients that reported
complaints is depicted.
RC (nZ65) BC (nZ28) Loop (nZ27)
Cold sensation 12 50* 26
Sensibility change 28 50* 17
Cramps 25 46* 30
At least one complaint 38 79* 52
*P!0.05 vs RC, prosthesis.In general, none of the investigational tests was sensitive enough to diagnose a steal effect. Compression of the
fistula led to a significant increase in finger pressure (mmHgGsem): open fistula: 94G6, compressed fistula:
129G7, contralateral hand: 127G5 mmHg, p!0.05). NIRS did not show any alterations in tissue oxygenation
before and during hemodialysis.
Conclusions:
Patients with an elbow fistula experience more complaints associated with reduced hand circulation compared
to patients with a RCAVF or a prosthetic loop graft. Low finger pressures are common in all types of
hemodialysis accesses.
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THE VASCULAR SURGEON FACING CLINICAL ETHICAL DILEMMAS: ‘V’-SHAPED ASSOCIATION
BETWEEN COMPASSIONATE ATTITUDES AND PROFESSIONAL SENIORITY
Introduction—Aim of Study:
Objective: To evaluate the association between compassionate attitudes and seniority in vascular surgeons (VS)
facing clinical ethical dilemmas (CED).
Materials/Methods:
Subjects: VS from 28 teaching departments (public hospitals) of one European Country.
Measurements: Multidisciplinary team-designed, structured and self-administered questionnaire of five CED
from which four showed a conflict between a compassionate attitude promoting a ‘small’ or ‘very costly’
beneficent action and an alternative approach in which the VS favoured a more ‘reasonable’ and pragmatic
resource allocation. Participants stated their degree of agreement with eight closed answers representing both
attitudes on a continuous Likert scale.
Statistics: cluster analysis and logistic regression model adjusted by confounding factors.EJVES Extra Vol 11, April 2006
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Two hundred and fifty-three VS (median age 37 years, 74% male) completed the questionnaire (87.5%
surgeons/department). Cluster analysis identified two groups of VS according to their pattern of answers:
group I (nZ63) were mainly compassionate whereas group II (nZ180) were mainly pragmatic. The multivariate
analysis disclosed, after adjusting for additional private practice, on call services and career status, a significant
V-shaped relationship between the compassionate behaviour and seniority, being surgeons with 8–15 years of
practice the least compassionate ones (Figure).
Conclusions:
The youngest and the most senior VS appear to favour compassionate rather than pragmatic attitudes when
facing CED. Although both attitudes may be ethically legitimate, physicians not promoting compassionate
attitudes in case of CED may be at risk of leaving the patient without advocate in the health system.
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TOTALLY LAPAROSCOPIC AORTIC REPAIR FOR OCCLUSIVE AND ANEURISMAL DISEASE: THE FIRST
95 CASES
Introduction—Aim of Study:
We present in this paper, the results of our preliminary experience of totally laparoscopic aortic repair for
occlusive or aneurismal disease.
Materials/Methods:
Since, September 2002 to April 2005, we underwent 95 aortic repair including 72 for aortic occlusive disease
(group A) and 23 for aortic abdominal aneurysm (group B). We used in all cases the coelioscopic retro colic aortic
approach described by Coggia.
Results:
In group A, the mean operative time was 216G50 min, mean clamping time was 57G21 min. There were
two surgical conversions (2.7%) and no postoperative mortality. There were also tree postoperative
complications including one retroperitoneal haematoma, an embolic sub ischaemia and one early prosthetic
infection. The mean length of hospital stay was 7G2 days. All grafts were patent at 2 months. In group B,
the mean operative time was 251G57 min, mean clamping time was 101G15 min. There were seven surgical
conversions (30%) and one postoperative death (4.3%) due to pulmonary embolism. In addition, there was
one retroperitoneal haematoma. The mean length of hospital stay was 6G4 days. All grafts were patent at 2EJVES Extra Vol 11, April 2006
ESVS Abstracts—2005 83months. The high conversion rate in group B is related to the learning curve and to the fact that we decided
in principle to do an open procedure after 2 h of coelioscopy when we were not ready at that time to clamp
the aorta.
Conclusions:
In conclusion, totally laparoscopic aortic repair appears to be feasible and safe for occlusive and aneurismal
aortic disease. However, current indications of total laparoscopic surgery should remain carefully planed.
Furthermore, this surgical technique requires an intensive training on pelvitrainer and a perfect knowledge of
human anatomy acquired on body dissection, to perform the coelioscopic anastomosis safely and to avoid
specific difficulties of this laparoscopic route.
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GROWTH RATE AND ASSOCIATED FACTORS IN SMALL ABDOMINAL AORTIC ANEURYSMS
Introduction—Aim of Study:
Objective. To calculate the growth rate of!5 cm infrarenal abdominal aortic aneurysms (AAA) and to identify
influencing factors.
Materials/Methods:
Patients and methods. We followed our patients with AAA !5 cm (January/88–August/04). We registered:
cardiovascular risk factors (CVRF), clinical characteristics, serial AAA diameters, and surgical procedures.
We calculated the mean growth rates (mm/year). We classified two groups: group I- AAA 3–3.9 cm (nZ
246), group II-AAA 4–4.9 cm (nZ106). Statistical analysis: chi-square, t-test, life tables, Kaplan–Meier,
logistic regression.
Results:
Results. We included 352 patients: 333 men (94.6%), 19 women (5.4%). Follow-up: 55.2G37.4 months (6.3–199.8).
The mean growth rate was significantly higher in Group II (4.72G5.93 vs 2.07G3.23; p!0.0001). Group II also
had a greater percentage of AAA with rapid expansion (O4 mm/year) (36.8 vs 13.8%; p!0.0001). The AAA
which have remained small (!5 cm) in groups I and II are: 100 and 74.4% after 1 year; 97.6 and 44.2% after 2
years; and 82.4 and 18.4% after 5 years, respectively (p!0.0001).
The classical CVRF have not influenced the rhythm of AAA growth in Group I. Chronic limb ischemia has been
associated with slow expansion (%4 mm/year) (RR 0.47;CI 95% 0.22–0.99; pZ0.045). AAA 3.5–3.9 cm (nZ91)
had a higher mean growth rate than AAA 3–3.4 cm (nZ155) (2.8G4.19 vs 1.65G2.41; pZ0.007).
Diabetic patients in group II have experienced a significantly lower mean AAA growth rate than non-diabetics
(1.69G3.51 vs 5.22G6.11; pZ0.032), with no influence of other risk factors. AAA 4–4.4 cm (nZ62) and 4.5–4.9 cm
(nZ44) had similar growth rates (4.5G5.38 vs 5.02G6.69; pZ0.66).
Conclusions:
Conclusions. AAAwith a diameter of 3–3.9 cm expands slowly, with a very low probability of requiring surgical
repair in 5 years. Over half of the AAAwith a 4–4.9 cm size reachR5 cm in the first 2 years of follow-up. The
larger the AAA, the higher the growth rate. Chronic limb ischemia reduces this rhythm of growth in !4 cm
AAA, and diabetes reduces it in 4–4.9 cm AAA.
37
Hynes N, Mahendran B, Tawfik S, Asad J, Andrews E, Ishtiaq A, Courtney D, Davidson I,
Sultan S
Department of Vascular and Endovascular Surgery, Western Vascular Institute, University
College Hospital Galway, IrelandEJVES Extra Vol 11, April 2006
ESVS Abstracts—200584A COMPARISON OF OPEN (OR) AND ENDOVASCULAR ABDOMINAL AORTIC ANEURYSM REPAIR
(EVAR) WITH BEST MEDICAL TREATMETN (BMT). HAS THE AVAILABILITY OF EVAR EXPANDED OUR
INDICATIONS FOR INTERVENTION, AND IMPROV
Introduction—Aim of Study:
Aim of our study is to investigate whether EVAR has prolonged life expectancy in high-risk patients with AAA.
Materials/Methods:
From 2002 to 2005, 780 patients with AAAwere referred to our service. One hundred and fifteen patients were
deemed high risk according to American Society of Anaesthesiologists classification and were prospectively
assigned to OR (nZ33), EVAR (nZ37) or BMT (nZ45). Adjustments were made for case severity mix and
patients were stratified using the SVS/AAVS co-morbidity and anatomic factor severity scores. All patients were
assessed using CT Angiography. The groups were matched for aneurysmal site, size, aetiology, clinico-
pathological manifestations and gender.
Results:
Patients in BMT were significantly older than in the other two groups (p!0.01), but there was no statistical
difference in combined medical comorbidity severity scores between the groups (pO0.05). Comparing EVAR
with OR, there was no significant difference in primary technical and clinical success rates (pO0.05), but length
of hospital stay and 30-day morbidity were significantly reduced in EVAR (pZ0.0004, p!0.01, respectively).
There were six incidences of type II endoleaks in the EVAR group, and fiv resolved without secondary
intervention.
The 3-year cumulative survival rates were 84% (SE 6.06%) for EVAR, 84% (SE 7.47%) for OR, and 68% (SE
7.4%) for BMT. Compared to BMT relative risk reduction ratio for all cause mortality was 0.527 (95% CI
0.218–1.323) for EVAR and 0.54 (95% CI 0.322–1.38) for OR. There was one aneurysm related death in the
OR group, and none in the EVAR group. The 1-year rupture rate in the BMT group was 11%, of which
80% died.
Conclusions:
EVAR is an alternative to patients at high risk for open repair, with a significant reduction in morbidity risk
compared to best medical treatment. At 1 year no statistically significant survival benefit was seen between the
three groups. However, survival curves continue to diverge at 3 years.
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SELF-EXAMINATION IN SCREENING FOR CLINICALLY SIGNIFICANT ABDOMINAL AORTIC
ANEURYSMS
Introduction—Aim of Study:
The Multicentre Aneurysm Screening Study (MASS) (Lancet 2002;360:1531–39), showed AAA screening
with abdominal ultrasonography reduces the incidence of rupture by 49%, and aneurysm related
mortality by 42%. However, cost effectiveness analysis (BMJ 2002;325(7373):1135–40) showed the cost of a
quality-adjusted life year (QALY) as £36,000 for the 1st year. We propose a hybrid-screening programme
with self-examination and abdominal ultrasound scan only in patients with a positive result, lowering
costs to an acceptable level for a national screening programme. The aim, therefore, was to (i) to assess
the sensitivity and specificity of self-examination in the detection of clinically significant (O5 cm) AAA
in the community. (ii) To assess the psychological consequences of screening for AAA by
self-examination.EJVES Extra Vol 11, April 2006
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Thousand male patients, age 65 and above, were invited to participate in the screening programme by postal
questionnaireusinganovel techniqueof self-examinationdescribed inapreviouslyvalidated study.Allparticipants
then had abdominal ultrasonography to determine aortic diameter. The psychological consequences of screening
were assessed with the SF-36 (Short Form-36) health survey questionnaire, and HAD (Hospital Anxiety and
Depression) scale, at the time of self-examination, after ultrasound scanning and 1 month after.
Results:
Six hundred and ninty-one patients (69%), median age 72(65–93) agreed to take part in the study. 20 AAAs were
detected by abdominal ultrasonography, of which six were O5 cm. Sensitivity for self-examination in the
detection of AAAO5 cm was 83.3%. The specificity for self-examination in detecting AAA was 85.5%. Mental
healthwas affected on introduction of screening but improved significantly (p!0.021) following the scan. Similar
results were obtained with HAD scale, with the patient’s anxiety levels improving (p!0.020) following the scan.
Conclusions:
Screening for AAA by self-examination is effective for clinically significant AAAs, and causes mild but transient
psychological stress. Full cost effectiveness analysis would be the next step in examining this hybrid screening
programme.
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A META-ANALYSIS OF 12 YEARS OF ENDOVASCULAR INFRA-RENAL AORTIC ANEURYSM REPAIR
Introduction—Aim of Study:
Endovascular repair of abdominal aortic aneurysm (AAA) is a new technique with unknown potential, and
reported rates of endoleak, conversion to open repair, rupture and mortality vary widely. The aim of this study
was to estimate these rates from the published data, and determine how this has changed as more patients have
undergone endovascular repair (ER).
Materials/Methods:
Ameta-analysis of all publications quoting endoleak, conversion to open repair, rupture and mortality rates for
a series of consecutive patients undergoing ER. Data was collected from 165 studies, including results from
28,862 endovascular aneurysm repairs.
Results:
The pooled estimate for type 1 endoleaks was 10.5%, with an annual rate of 8.4%. The pooled estimate of type 2,
3 and 4 endoleaks was 13.7%, with an annual rate of 10.2%. The pooled estimate for primary conversion to open
repair was 3.8%, and for secondary conversion to open repair 3.4%. The pooled estimate for post-operative
rupture was 1.3%, with an annual rupture rate of 0.6%. The pooled estimate for operative mortality was 3.3%.
Multivariate meta-regression analysis showed that rates of operative mortality, post-operative rupture and total
number of endoleaks all fell significantly (p!0.05) over time.
Conclusions:
This study demonstrates a gradual reduction in vascular morbidity and mortality associated with endovascular
repair since endovascular repair was first introduced
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STENT-GRAFT REPAIR
Introduction—Aim of Study:
Endovascular repair of the thoracic aorta often involves proximal device attachment near or within the aortic
arch. Coverage-exclusion and/or transposition of arch branches are frequently required to facilitate or enable
stent-graft placement. The outcome of such procedures has not been closely scrutinized or reported.
Materials/Methods:
Sixty-seven patients (67/215, 31%) underwent 80 arch-branch exclusion and/or transposition/bypass
procedures prior to or during thoracic stent-grafting in the 93-month period ending 12/31/04. Coverage-
exclusion of the left subclavian artery (CE-LSA) numbered 56, left subclavian or axillary bypass/transpositions
8, and carotid-to-carotid bypass (CCB) with ligation of the proximal left carotid artery 16. One additional patient
had right femoral artery-based arch revascularization. All procedures involved use of the Medtronic Talent
thoracic endograft.
Results:
CE-LSA procedures caused arm claudication in 30% (17/56). It proved persistent in three, one requiring
secondary revascularization at 6 months. Symptoms improved or resolved in all others (follow-up range 1–51
months). One patient (1/56, 1.8%) died at 5 days from cerebellar stroke. There were no mortalities with carotid-
subclavian or axillary bypasses; one patient suffered transient phrenic nerve palsy, and another required
reoperation for evacuation of hematoma. One bypass graft occluded at 3 months (follow-up 20–40 months). One
patient with a CCB died in the recovery room from rupture of the thoracic aneurysm (prior to stent-graft repair).
There were no strokes or reinterventions (follow-up 1–42 months). One patient suffered transient laryngeal
nerve injury.
Conclusions:
Arch-branch exclusions and transpositions appear to be well tolerated as they involve extrathoracic cervical
operations or endovascular maneuvers performed at the time of endograft thoracic intervention. Complications
rates are low. The fact that branched endograft technologies are not widely available at present underscores the
practical usefulness of these procedures that are designed to optimize and expand stent-graft approaches for
endovascular repair of a host of thoracic aortic pathologies.
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ENDOVASCULAR REPAIR FOR AORTO-ENTERIC FISTULA: A BRIDGE TOO FAR OR A BRIDGE TO
SURGERY?
Introduction—Aim of Study:
Although relatively uncommon, aorto-enteric fistula (AEF) remains a severe complication after aortic surgery.
Untreated, AEF is almost always fatal. Because of the high morbidity and mortality rate of conventional surgical
treatment, the use of an aortic endoprosthesis has been described with various outcomes. We present a
retrospective analysis of 15 patients.
Materials/Methods:
Between March 1999 and March 2005, 15 patients in five university and teaching hospitals in Belgium and
the Netherlands were treated in an endovascular way for AEF. Twelve (80%) were male, aged 42–82 years. 13
(87%) had had previous aortic or iliac surgery, 1.7–307 months before. All patients showed clinical orEJVES Extra Vol 11, April 2006
ESVS Abstracts—2005 87biochemical signs of bleeding. Eight (53.33%) were in shock, five (33.3%) had systemic signs of infection.
Eight (53.3%) patients were treated in an emergency setting. Ten (66.67%) were treated with an
aortomonoiliac device, three (20%) with an aortobiiliac device, one with a tube graft and one with
occluders only. All patients received antibiotics postoperatively for a prolonged period of time.
Results:
All AEF were successfully sealed, the 30-days mortality was 0%. Mean hospital stay was 20(2–81) days. One
patient died 2.7 months later of postoperative complications, one died of lung cancer. Until now, there are no
signs of reinfection in five (33.3%) patients (mean follow-up 14.9(1–44) months). However, reinfection or
recurrent AEF occurred in eight (53.33%) patients after 10.6(0.61–30.7) months. Six patients were reoperated
successfully, two patients died after reintervention.
Conclusions:
Endovascular sealing of AEF is a promising technique, which provides time to treat shock, local and systemic
infection, and co-morbidity. This creates a better situation to perform open repair in the future with possible
better outcome. Danger of reinfection remains high. Endovascular sealing of AEF should, therefore, be seen as a
bridge to open surgery when possible.
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PRELIMINARY RESULTS IN REVAR; A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL
OF ENDOVASCULAR (EVAR) VS OPEN REPAIR OF RUPTURED ABDOMINAL AORTIC ANEURYSMS
Introduction—Aim of Study:
EVAR has the potential to improve outcome after ruptured AAA. Published series have been based on selected
populations.
Materials/Methods:
An interim analysis of a single centre prospective randomized controlled trial comparing endovascular
aneurysm repair (EVAR) with open aneurysm repair (OAR) in patients with ruptured AAAwas done. Patients
who had a ruptured AAA and who were considered fit for open repair were randomised to EVAR or OAR after
consent had been obtained. Those in the EVAR group had preoperative spiral computed tomography
angiography. The primary endpoint was operative (30-day) mortality and secondary endpoints were moderate
or severe operative complications, hospital stay and time between diagnosis and operation. A power study
calculation required 100 patients to be recruited.
Results:
Between September 2002 and December 2004, over 100 patients were admitted with suspected ruptured
AAA. Some 32 patients were randomised. Four patients died before receiving surgical treatment. Operative
mortality rate was 38.5% in the EVAR group and 40% in the OAR group. Moderate or severe operative
complications occurred in 77% in the EVAR group and in 80% in the OAR group. Median total hospital
stay in the EVAR group was 10 days (IQR 6–28) and 12 days (IQR 4–52) in the OAR group. Median time
between diagnosis and operation was 75 min (IQR 64–126) in the EVAR group and 100 min (IQR 48–138) in
the OAR group.
Conclusions:
Despite the relative high operative mortality in the EVAR group, these preliminary results show that it is
possible to recruit patients to a randomised trial of OAR and EVAR in patients with ruptured AAA. More
evidence is necessary to show that EVAR is better than OAR in ruptured AAA. Based on this information, future
trials need to be larger than expected to show a difference in outcome.EJVES Extra Vol 11, April 2006
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THROMBOLYSIS FOR ACUTE LOWER LIMB ISCHEMIA—A PROSPECTIVE, RANDOMIZED,
MULTICENTRE STUDY COMPARING TWO STRATEGIES
Introduction—Aim of Study:
Acute thrombo-embolic occlusions of lower limb arteries are commonly treated with thrombolysis as initial
treatment. This can either be performed with a pulse-spray, high-dose technique followed by low-dose infusion
if needed or with initial end-hole, low-dose infusion.
Materials/Methods:
One hundred and twenty-one patients (52% males, mean age 72 years) with unilateral, acute (!30 days) lower
limb ischemia were randomized following initial angiography. Systemic heparin infusion (600 IU/h) was
combined with intra-thrombotic rt-PA (ActilyseO`). Group 1 (nZ58): Pulse-spray infusion with 15 mg/h for 2 h
followed by low-dose rt-PA (0.5 mg/h) if needed. Group 2 (nZ63): Low-dose infusion of rt-PA (0.5 mg/h) for
27G13 (maximum 48) h. There were no group differences in sex, age, risk factors, occlusion level, or duration
and severity of presenting symptoms.
Results:
Significant (O75%) thrombolysis was accomplished in 78% of the patients in group 1 and in 67% in
group 2 (n.s.), and complementary PTA/stenting was performed equally frequent (63%). Endpoint
(reocclusion, incomplete lysis, life-threatening complication, amputation, or death) had been reached
within 30 days in 31 and 38% of the patients and patency of the affected segment was 81 and 68%,
respectively (n.s.). During the 1st year, additional procedures were performed in 26 and 43%, respectively
(pZ0.05, chi-square), and reocclusion of the affected segment tended to occur more frequent in group 2
(pZ0.053, life-table, log rank test).
Conclusions:
There was no difference in the previously established endpoints. However, initial high-dose, pulse-spray
thrombolysismayproduceamoreeffectivethrombolysisproducingbetter long-termpatencyoftheoccludedarteries.
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QUANTIFICATION AND CHARACTERIZATION OF CAROTID CALCIUM WITH MULTI-DETECTOR
CT-ANGIOGRAPHY
Introduction—Aim of Study:
Calcification of atherosclerotic plaques is considered to be a major drawback for imaging carotid artery (duplex
scanning, angiography, MR-angiography). Only recently, multi-detector CT-angiography has demonstrated its
reliability for identifying calcium in the arterial wall. Aims: (1) To characterize the content and distribution
pattern of calcifications in carotid bifurcations. (2) To assess its relationship with neurological symptoms in a
case-control study.
Materials/Methods:
Design: Case-control study. Setting: University hospital. Population: 32 consecutive patients submitted for
CT-angiography to assess stenosis of the internal carotid artery (ICA): 1) Cases: 19 symptomatic patients (stroke:11;
TIA:2; ocular symptoms:5). Controls: 13 asymptomatic patients. Determinations: Calcium quantification withEJVES Extra Vol 11, April 2006
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calibrate CT-angiography imaging parameters. Calcium content (calcification volume (mm3), CV); and average
calcium density (Hounsfield units (HU), CD) were determined bymeans of CT-angiography in those patients with
ICA stenosisO60% (13 symptomatic, 13 asymptomatic). 3. Distribution pattern of calcium within the lesion
(posterior, heel or lumen) was assessed in all cases. Statistical analysis: Non-parametric comparison of means
(calcium content), and frequencies (calcium distribution); multivariate analysis (clinical and laboratory variables).
Results:
1. Asymptomatic patients with ICA stenosisO60% showed statistically significant higher content of calcium
than those who were symptomatic (calcium score (CV!CD): 122.6G138.0HU.mm3 vs 42.8G59.1HU.mm3,
p!0,05). 2. Asymptomatic lesions showed calcification in the surface or heels of the plaque in a higher
proportion than symptomatic ones (9/12(75%) vs 3/15(13,3%); p!0.005;NA 5). 3. No other clinical or laboratory
data showed statistical association with neurological symptoms.
Conclusions:
1. CT-angiograpghy permits the reliable quantification of calcification of atherosclerotic plaques. 2. In this study,
a lower content of calcium in carotid plaques, as well as its distribution in the base of the lesion, was associated
with a greater prevalence of neurological symptoms. 3. These parameters may be useful to identify those
patients at higher risk of stroke.EJVES Extra Vol 11, April 2006
